This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Johnson & Johnson
Drug Names(s): Ketamine
Description: Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist, and has been reported to have effects on other receptors as well (opioid, monoaminergic, muscarinic, and voltage sensitive Ca ion channels, but not GABA receptors). At lower doses than that approved for use as an anesthetic, ketamine has been reported in the medical literature to be an effective medication for the treatment of postoperative pain, neuropathic pain and pain during emergency medical procedures.
Pink Sheet FDA Performance Tracker: User Fee Goal Dates
Additional information available to subscribers only: